IP Library Granted Patent US 8,633,311
Granted Patent B2
US 8,633,311 · App. 13/056,441 · Granted Jan 21, 2014

Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal

Inventors: Jerry C. Bommer (Franklin, ID); Glenn Prestwich (Eastsound, WA); Charles Testa (Salt Lake City, UT)
Assignee: Frontier Scientific, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,633,311
App. No.
13/056,441
Granted
Jan 21, 2014
Kind
B2
Abstract

Described herein are methods and compositions for killing or preventing the growth of microbes. It has been discovered that a class of porphyrins can kill or prevent the growth of microbes. The porphyrins can be used in a number of different applications where microbes grow.

Claims (17)

1. A method for killing or preventing the growth of a bacterium or a fungus on a mammal, the method comprising topically applying to the mammal a topical composition comprising a pharmaceutical carrier and a porphyrin of the formula I

wherein R 1 is a C 12 straight chain alkyl group;

R 2 -R 4 are each a methyl group; and

X − is an anion.

2. The method of claim 1 , wherein X is a halide, sulfate, acetate, lactate, nitrate, phosphate, carbonate, bicarbonate, or tosylate.

3. The method of claim 1 , further comprising exposing the porphyrin to light after topically applying the composition to the mammal.

4. The method of claim 3 , wherein when the light comprises artificial light, the light has an intensity of at least 5 mW/cm 2 .

5. The method of claim 3 , wherein when the light comprises artificial light, the light has an intensity of 5 mW/cm 2 to 500 mW/cm 2 .

6. The method of claim 3 , wherein the light comprises sunlight.

7. The method of claim 1 , wherein the porphyrin is exposed to light under aerobic conditions.

8. The method of claim 1 , wherein the pharmaceutical carrier is a powder.

9. The method of claim 1 , wherein the pharmaceutical carrier is an ointment.

10. The method of claim 1 , wherein the pharmaceutical carrier is a cream.

11. The method of claim 1 , wherein the pharmaceutical carrier is a gel.

12. The method of claim 1 , wherein the pharmaceutical carrier is a spray.

13. The method of claim 1 , wherein the method kills or prevents the growth of bacterium.

14. The method of claim 1 , wherein the method kills or prevents the growth of a fungus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2021
From: FRONTIER SCIENTIFIC INC.
To: FRONTIER SPECIALTY CHEMICALS INC.
Reel/Frame 058393/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2011
From: PRESTWICH, GLENN; BOMMER, JERRY C.; TESTA, CHARLES
To: FRONTIER SCIENTIFIC, INC.
Reel/Frame 026120/0726 →
Continuity (2)
Provisional Application 61084403 · Jul 29, 2008
Related Publication 20120016289A1 · Jan 19, 2012